Contract Research Organization List

If you're interested in a Contract Research Organization List, you've come to the right place. You can find information about companies like Vial CRO., Syneos Health, EPS International, Clinipace, and others. As per Contract Research Organization List, These companies offer services that are essential to the pharmaceutical industry.

Vial CRO

Vial is an American biopharmaceutical company that supports biotechnology and pharmaceutical companies with research and development. The company conducts clinical research and trials of drugs before they are released. It also provides laboratory services to the chemical and agrochemical industries. Its headquarters is located in Princeton, New Jersey. In 1989, Vial imported macaque monkeys from the Philippines for its animal-testing unit. These monkeys were infected with a type of Ebola virus. In the mid-1990s, the company ceased operations of the monkey house.

Vial is a contract research organization (CRO) that offers early-stage services to biotechnology, pharmaceutical, and medical device companies. It also provides laboratory testing and discovery services to the agrochemical and chemical industries. The company also provides clinical trials and commercialization services for new products. It employs more than 12,500 individuals in 60 countries and reported revenues of $2.5 billion in 2013.

In April 1999, Vial announced an agreement to buy Parexel International Corp., the third-largest clinical trials company in the world. The purchase was worth $671 million and would have allowed Vial to surpass Quintiles Transnational Corp. in size. However, investors were not happy with the deal and Vial stock dropped by 25 percent after the announcement. Despite the gloomy outlook, Parexel was the largest stockholder in Vial, with nearly 15 percent of shares being held by Wellington Management Co. Moreover, Vial had a long-term debt of $150 million.

The deal between LabCorp and Vial will result in the creation of the world's largest pharmaceutical testing and diagnostics firm. Together, the two companies will become a full-service drug development organization and the leading provider of medical testing and nutritional analysis. The deal is expected to create synergies of $100 million within the next three years. Moreover, Vial's operational headquarters will remain in Princeton, New Jersey, with CEO Joe Herring continuing to lead the company.

Syneos Health

The Syneos Health contract research organization has 42 services in its portfolio. The company provides support for all stages of clinical research. It also offers functional services. This company is headquartered in Northern Carolina and employs more than 25,000 people in 91 locations around the world. It has recently announced a strategic partnership with Elligo, a clinical research infrastructure platform. This partnership aims to create a centralized infrastructure for both physicians and patients.

In 2018, the company reported $2.567 billion in revenue. Its Core platform helps the Pharma and biomedical industries develop new drugs and commercialize them. Its platform supports biopharmaceutical development and commercial outsourcing. The organization's partnerships are designed to improve the speed of drug development.

The company provides a variety of services to its clients, including consulting, market access, brand commercialization, portfolio strategy, and future commercial models. It is headquartered in Morrisville, North Carolina, and employs over 24,000 people in 91 locations. It is a publicly traded company and has offices around the world.

The company has offices in more than 60 countries and has expertise in many therapeutic areas. It has a strong presence in areas such as cardiovascular, metabolic, oncology, rare diseases, and general medicine. It also has offices in Europe and Asia-Pacific regions. It has a broad range of services, and is a great choice for contract research.

EPS International

The EPS International Contract research organization list includes a range of companies that provide a broad range of research and development services. These companies provide comprehensive services, including clinical trials, drug development, and data management. These organizations help pharmaceutical companies conduct research and development for various diseases and medical products. The Contract research organization list also includes biotechnology and biomedical services companies.

North America dominated the market in 2018. It is expected to witness a substantial growth over the next few years, owing to the growing number of pharmaceutical companies and increasing spending on R&D activities. North America's contract research organization market is expected to grow at the fastest rate due to the increasing number of clinical trials conducted in the region. The region's growth is also attributed to a growing elderly population with chronic diseases.

Global Contract Research Organization (CRO) and CDMO Market is valued based on segmental revenue. It provides a snapshot of competition, key trends, and principal factors affecting the industry. It also includes a Contract research organization list of the leading manufacturers. It also analyzes the impact of COVID-19 on the market.

Clinipace

Founded in Morrisville, NC, Clinipace is a global, full-service CRO with a focus on customized solutions for clinical trials. With offices across North and South America, Europe, and the Asia-Pacific region, the CRO is well-positioned to meet the needs of a wide range of clients. The company focuses on a number of therapeutic areas, including oncology, rare diseases, cardiology, and immunology.

The company has a global presence with offices in more than 60 countries. It has experience in a number of therapeutic areas including oncology, metabolic, and cardiovascular, as well as rare diseases and general medicine. Its expertise includes drug development, clinical trial management, and regulatory support.

The firm is a digital contract research organization (CRO) that focuses on serving strategic, mid-tier, and venture-backed biotechnology companies. The company has recently announced a strategic alliance with CRO Medfiles, a Finland-based company that has been serving the Nordic and Baltic regions for 25 years. The combined geofootprint of the two companies provides new global opportunities for clients, allowing them to take advantage of both organizations' expertise and proprietary technology.

The Contract research organization list includes Illingworth Research, which provides clinical development services as well as research nurses for patient homecare. Kemwell, a CRO in Bangalore, India, is a contract biologics development company with facilities designed with the support of German Pharma. In addition to these CROs, Synteract is a privately owned CRO specializing in the emerging biopharma industry.

Parexel

Parexel is a contract research organization (CRO) with a commitment to streamlining clinical trial operations for its clients. The company was recently recognized as the "Best Contract Research Organization" in the Full-Service Provider category at the Digital 16th Annual Scrip Awards. The award was presented in a virtual ceremony on Dec. 2. Parexel was also recognized for its commitment to the clinical research industry, including its commitment to providing the highest quality patient recruitment and data collection.

Parexel provides a full range of clinical trial services to pharmaceutical and biotechnology companies. These services include regulatory expertise, clinical trial operations management, medical education, and communication capabilities. In addition, Parexel has a comprehensive network of clinical research facilities across the world. Its headquarters are located in Durham, North Carolina, and Newton, Massachusetts.

Parexel has offices in over 30 countries and has been in business since 1983. During this time, it has acquired many other companies and increased its revenue to more than $350 million. Its Informatics division has helped accelerate the drug development process. Other services include clinical trial supplies and logistics, patient services, and education. In 2013, Parexel acquired Rescon Inc., a medical marketing consulting company.

In addition, it acquired Perceptive Systems Inc., which provides high-resolution image optical recognition software, as well as Kemper-Masterson, a validation and compliance services provider. In addition, the company expanded its presence internationally with the purchase of PPS Europe Ltd. and Sheffield Statistical Services, both of which were located in the United Kingdom. The company also acquired a stake in Groupe PharMedicom in France and Logos GmbH in Germany.

The CRO sector has continued to grow in the last decade, though the last year was a difficult time for many clinical trials. This is largely due to the pandemic, which stopped many clinical trials. However, the contract research organization industry continues to evolve and the growth of the CRO industry is expected to increase over the next few years. As a result, Parexel has an increased opportunity for double-digit earnings growth.